Changes in quality of life of early-stage lung cancer patients undergoing sublobar resection: a systematic review

被引:0
作者
Magouliotis, Dimitrios E. [1 ]
Cioffi, Ugo [2 ]
Minervini, Fabrizio [3 ]
Lampridis, Savvas [4 ]
Guttadauro, Angelo [2 ]
Scarci, Marco [5 ]
机构
[1] Lankenau Inst Med Res, Dept Cardiac Surg Res, Wynnewood, PA USA
[2] Univ Milan, Dept Surg, Milan, Italy
[3] Cantonal Hosp Lucerne, Div Thorac Surg, Luzern, Switzerland
[4] 424 Gen Mil Hosp, Dept Thorac Surg, Thessaloniki, Greece
[5] Hammersmith Hosp, Imperial Coll Healthcare, Dept Cardiothorac Surg, Natl Hlth Serv NHS Trust, London, England
来源
FRONTIERS IN SURGERY | 2025年 / 12卷
关键词
quality of life; sublobar lung resection; lobectomy; lung cancer; stereotactic body radiotherapy (SBRT); HEALTH SURVEY; LOBECTOMY; RADIOTHERAPY; RELIABILITY; VALIDITY;
D O I
10.3389/fsurg.2025.1542036
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: This systematic review aimed to evaluate the impact of sublobar resection (SLR) on the quality of life (QoL) of patients with early-stage non-small cell lung cancer (NSCLC). Specifically, it compared outcomes between sublobar resection, lobectomy, and stereotactic body radiation therapy (SBRT). Methods: A literature search was conducted across PubMed and Scopus, identifying studies published from 2010 to 2024 that reported QOL outcomes in early-stage NSCLC patients treated with lobectomy, SLR, or SBRT. Inclusion criteria were studies with more than 10 patients, written in English, and using validated QoL metrics. Data on demographics, interventions, QoL tools, and findings were extracted, and study quality was assessed using the Newcastle-Ottawa Scale and the ROBINS-I tool. Results: Five studies involving 1,149 patients from six countries met the inclusion criteria. QoL outcomes consistently favored SLR over lobectomy in domains such as physical and respiratory function, with SLR patients experiencing faster recovery and fewer complications. Minimally invasive techniques, such as video-assisted thoracoscopic surgery (VATS), further enhanced these outcomes. SBRT demonstrated stable QOL post-treatment but lacked the long-term physical recovery benefits observed with SLR. Commonly employed QoL tools included the EORTC QLQ-C30, Leicester Cough Questionnaire, and NSCLC-PQOL, each capturing distinct dimensions of patient QoL status. Conclusion: Sublobar resection provides significant QoL benefits for selected early-stage NSCLC patients compared to lobectomy, particularly in respiratory health and recovery endpoints. These findings highlight the value of personalized surgical approaches and the need for further research on optimizing QoL in NSCLC management.
引用
收藏
页数:10
相关论文
共 33 条
  • [21] Saji H., Okada M., Tsuboi M., Nakajima R., Suzuki K., Aokage K., Et al., Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607l): a multicentre, openlabel, phase 3, randomised, controlled, non-inferiority trial, Lancet, 399, pp. 1607-1617, (2022)
  • [22] Iovoli A.J., Yu B., Ma S.J., Farrugia M.K., Dexter E.U., Yendamuri S., Et al., Quality of life after stereotactic body radiation therapy or surgery for early-stage NSCLC: a systematic review, JTO Clin Res Rep, 3, 11, (2022)
  • [23] Bendixen M., Jorgensen O.D., Kronborg C., Andersen C., Licht P.B., Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial, Lancet Oncol, 17, pp. 836-844, (2016)
  • [24] Cocks K., Wells J.R., Johnson C., Schmidt H., Koller M., Oerlemans S., Et al., Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer, Eur J Cancer, 178, pp. 128-138, (2023)
  • [25] Hircock C., Wang A.J., Goonaratne E., Sferrazza D., Bottomley A., Cella D., Et al., Comparing the EORTC QLQ-LC13, EORTC QLQ-LC29, and the FACT-L for assessment of quality of life in patients with lung cancer: an updated systematic review, Curr Opin Support Palliat Care, 18, 4, pp. 260-268, (2024)
  • [26] Ware J.E., Kosinski M., Keller S.D., A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity, Med Care, 34, 3, pp. 220-233, (1996)
  • [27] Stewart A.L., Hays R.D., Ware J.E., The MOS short-form general health survey, Med Care, 26, 7, pp. 724-735, (1988)
  • [28] Nguyen A.M., Schelfhout J., Muccino D., Bacci E.D., La Rosa C., Vernon M., Et al., Leicester cough questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough, Ther Adv Respir Dis, 16, (2022)
  • [29] Eguchi T., Kaseda K., Lu S., Vincent M., Segmentectomy for stage I non-small cell lung cancer: advantages and challenges, Ann Thorac Surg, 108, 2, pp. 363-369, (2019)
  • [30] Darling G.E., Allen M.S., Decker P.A., Ballman K., Malthaner R.A., Inculet R.I., Et al., Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial, J Thorac Cardiovasc Surg, 141, 3, pp. 662-670, (2011)